ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

Contributed by: Business Wire

Logo

Tags

Research

Technology

Clinical Trials

Professional Services

Biotechnology

Pharmaceutical

Health

Environmental, Social and Governance (ESG)

Science

Artificial Intelligence

Award

More Like This

ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer

ICON plc Schedules Third Quarter 2024 Earnings Conference Call

Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON

ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape

ICON Announces Pricing of USD 2 Billion Notes

ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance

ICON Issues Financial Guidance for Full Year 2024

ICON Reports Third Quarter 2023 Results